Investor insights
Sectors invested in
Funding rounds participated in
$77M sweet spot round size
Most of their 11 investments are in rounds between $31M and $120M
Investor type
Basic info
Industry
Sectors
Date founded
2010
Investments made
ArriVent Biopharma raised $155M on December 29, 2022
Investors: Octagon Capital Advisors, Lilly Asia Ventures, Sofinnova Ventures, Russia technology fund, Sequoia Capital China, Unicorn Capital Partners 獨秀資本 and Sirona Capital
CG Oncology raised $120M on November 15, 2022
Investors: RA Capital Management, L.P., Acorn Bioventures, ORI Capital Limited, Longitude Capital, Decheng Capital and Sirona Capital
Fuse Biotherapeutics raised $9.5M on November 15, 2021
Investors: Viva BioInnovator, 夏尔巴股权投资管理有限公司 and Sirona Capital
Antiva Biosciences, Inc. / previously know as Hera Therapeutics raised $31M on November 2, 2021
Investors: Mana Ventures, Canaan, Lumira Ventures, Osage University Partners (OUP), Sofinnova Ventures, Russia technology fund, GV and Sirona Capital
Antiva Biosciences, Inc. / previously know as Hera Therapeutics raised $15M on July 10, 2018
Investors: NS Investment, JLABS, Canaan, Osage University Partners (OUP), Brace Pharma Capital, Hillhouse Capital Management, Sofinnova Ventures, Russia technology fund and Sirona Capital
Constellation Pharmaceuticals raised $100M on April 9, 2018
Investors: NS Investment, The Column Group, OrbiMed Advisors, S.R. One Ltd, Venrock, Solon Mack Capital, Third Rock Ventures and Sirona Capital
Arvinas raised $55M on April 4, 2018
Investors: Nextech Invest, 5AM Ventures, New Leaf Venture Partners, OrbiMed Advisors, Hillhouse Capital Management, Canaan, RA Capital Management, L.P. and Sirona Capital
TCR² Therapeutics Inc. raised $125M on March 21, 2018
Investors: Syno Capital, Redmile Group, Hillhouse Capital Management, UBS Asset Management, Mirae Asset MAPS Global Investments Co., Ltd, MPM Capital, Haitong International Securities Group Limited and Sirona Capital
Viela Bio raised $282M on February 28, 2018
Investors: 6 Dimensions Capital, Temasek, Hillhouse Capital Management, Boyu Capital and Sirona Capital
HOOKIPA Pharma Inc. raised $60M on December 11, 2017
Investors: The Gilead Group, LLC, HBM Partners AG, Hillhouse Capital Management, Forbion, BioMedPartners, Takeda UK Limited, Sofinnova Partners and Sirona Capital